Hannah Ziegler / nytimes - Officials said one person was killed and 20 others were poisoned after eating death cap mushrooms, which look and taste like safe mushrooms but can cause liver failure.
#healthcare #publichealth #governmentpolicy
Saturday, December 6, 2025, 8:21 pm / permalink 16668 / 3 stories in 3 months
Frank Vinluan / medcitynews - Protego Biopharma’s lead program is a potential treatment for the rare disease light chain amyloidosis. The startup says the novel mechanism of its oral small molecule should have better outcomes than antibodies from AstraZeneca and Prothena that failed t…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment
Saturday, December 6, 2025, 10:21 am / permalink 16661 / 2 stories in 3 months
medicalxpress - Previously unknown volcanic eruptions may have kicked off an unlikely series of events that brought the Black Death—the most devastating pandemic in human history—to the shores of medieval Europe, new research has revealed.
Saturday, December 6, 2025, 7:21 am / permalink 16655 / 3 stories in 3 months
oncodaily - Rabi Hanna, Chairman at Department of Pediatric Hematology-Oncology and BMT at Cleveland Clinic, shared a post on X: “Excited to participate in ASH-a-palooza at ASH25 BLOOD BUDDIES. Designed for undergraduates, medical […]
Saturday, December 6, 2025, 7:21 am / permalink 16654 / 27 stories in 3 months
HIMSS 2026 pushes real‑time data, cloud and interoperability playbook 14 stories in 18.5 hours
Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma 3 stories in 19.5 hours
Vitamin D trial shows reduced long‑COVID risk but no severity benefit 2 stories in 21.5 hours
Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival 4 stories in 22.4 hours
FDA approves leucovorin for rare folate disorder despite autism hype 4 stories in 34.5 hours
HORMAD1 emerges as a potential target in triple‑negative breast cancer 4 stories in 47.5 hours
Alfasigma pays $300M to GSK for linerixibat rights, expanding liver-disease portfolio 2 stories in 50.5 hours
Roche’s hoped‑for breast cancer pill fails crucial first‑line trial 5 stories in 51.5 hours
Novo Nordisk and Hims bury the hatchet and carve a deal 3 stories in 56.5 hours
AI improves UK breast-screening detection by about 10% 5 stories in 56.5 hours
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.
Bluesky: